Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2007
11/22/2007WO2007133491A1 Substituted spirocyclic cgrp receptor antagonists
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132307A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007WO2007132010A1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors
11/22/2007WO2007131764A2 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/22/2007WO2007077961A3 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
11/22/2007WO2007075783A3 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
11/22/2007WO2007062314A3 Heterocyclic cetp inhibitors
11/22/2007WO2005037805A3 1,2,4-thiadiazole compounds and pests controlling composition containing the same
11/22/2007US20070270570 White electroluminescent polymeric material and preparation thereof
11/22/2007US20070270475 4-Methoxy-Pyrrolidine-2-Carboxylic Acid Compounds and Derivatives Thereof as Hepatitis C Virus Inhibitors
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270439 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
11/22/2007US20070270426 Compounds for the treatment of neurodegenerative disorders
11/22/2007US20070270407 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070270386 Selective inhibitors of rock protein kinase and uses thereof
11/22/2007CA2652866A1 Therapeutic compounds
11/22/2007CA2652101A1 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007CA2651836A1 Selective inhibitors of rock protein kinase and uses thereof
11/22/2007CA2651822A1 Acetylenic heteroaryl compounds
11/22/2007CA2651629A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007CA2647238A1 2,4-diamino pyrimidines as cell cycle kinase inhibitors
11/21/2007EP1857442A2 Novel antimycobacterial compounds
11/21/2007EP1857104A1 Use of cinnamoyl compound
11/21/2007EP1856115A1 Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions
11/21/2007EP1856103A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
11/21/2007EP1856099A2 Acridine and quinoline derivatives as sirtuin modulators
11/21/2007EP1856098A2 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/21/2007EP1856097A2 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/21/2007EP1856082A1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
11/21/2007EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
11/21/2007EP1855688A2 Nitric oxide enhancing diuretic compounds, compositions and methods of use
11/21/2007EP1855672A1 Hiv protease inhibitors
11/21/2007EP1771444B1 Salt of oxalic acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)-amino)ethoxy]benzyl]thiazolidin-2,4-dione and a method of its preparation and its use
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007US7297714 Inhibitors of cathepsin S
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007CA2125236C Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
11/15/2007WO2007131179A1 Factor xa inhibitors
11/15/2007WO2007130075A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/15/2007WO2007130064A1 2-n-(5-[[4-(2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
11/15/2007WO2007129962A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129052A1 Pyrazole derivatives and their use as pi3k inhibitors
11/15/2007WO2007129044A1 Thiazole derivatives and their use as anti-tumour agents
11/15/2007WO2007128873A1 A method for the preparation of maleimido derivatives of biomolecule labeling reactants and conjugates derived thereof
11/15/2007WO2007128410A1 Insecticidal compounds
11/15/2007WO2007109578A3 Substituted gamma lactams as prostaglandin ep2 agonists
11/15/2007WO2007108744A3 Novel quinazolines as 5-ht6 modulators
11/15/2007WO2007108743A3 Novel quinazolines as 5-ht6 modulators ii
11/15/2007WO2007077186A8 Pdf inhibitors
11/15/2007WO2007076092A3 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
11/15/2007WO2007070600A3 N-(5-membered heteroaromatic ring)-amido anti-viral compounds
11/15/2007WO2007067836A3 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
11/15/2007WO2007067615A3 Thiadiazole derivatives as antidiabetic agents
11/15/2007WO2006122319A3 Histone deacetylase inhibitors
11/15/2007WO2002089799A3 Use of dihydropyrazoles to increase erythropoietin and vasculari zation
11/15/2007US20070265451 Process for the preparation of oxazolidinones and method of use thereof
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265446 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
11/15/2007US20070265321 1,1-dioxo-isothiazolidine; glaucoma or ocular hypertension; prostaglandin receptor inhibitors
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265313 Compositions use for increasing insulin sensitivity; formulations for minimizing the impurity associated with rosiglitazone maleate; safety and efficacy of product
11/15/2007US20070265312 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
11/15/2007US20070265302 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
11/15/2007US20070265265 Such as 2-{4-[4-(Cyclopentanecarbonyl-amino)-phenyl]-thiazol-2-ylcarbamoyl}-pyrrolidine-1-carboxylic acid benzyl ester; Flaviviruses
11/15/2007US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007CA2651303A1 Factor xa inhibitors
11/15/2007CA2649813A1 A system for wireless transmission of measurement results intended to be used in a coupling device and a use of the system in a vehicle
11/15/2007CA2647829A1 2-n-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
11/15/2007CA2618646A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/14/2007EP1854795A1 Salt of proline derivative, solvate thereof, and production method thereof
11/14/2007EP1854794A1 2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
11/14/2007EP1854789A1 Quinazoline derivative having tyrosine kinase inhibitory activity
11/14/2007EP1853598A2 Chemical probe compounds that become fluorescent upon reduction, and methods for their use
11/14/2007EP1853590A1 Fused heterocyclic compounds and their use as sirtuin modulators
11/14/2007EP1853587A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/14/2007EP1853586A1 Antibacterial piperidine derivatives
11/14/2007EP1853585A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters
11/14/2007EP1853583A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/14/2007EP1689231A4 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
11/14/2007EP1654261B1 Hepatitis c inhibitor compounds
11/14/2007EP1585541B1 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
11/14/2007EP1578745B1 BENZOFURAN DERIVATivES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES THEREOF
11/14/2007EP1495018B1 Tricyclic thrombin receptor antagonists
11/14/2007EP1483262B1 Coumarines useful as biomarkers
11/14/2007CN101072775A Novel mch receptor antagonists
11/14/2007CN101072768A 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of CNS disorders
11/14/2007CN101072758A 喹唑啉衍生物 Quinazoline derivatives
11/14/2007CN101072561A Diaminoalkane aspartic protease inhibitors
11/14/2007CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101070304A Quinoline derivatives and their use as mycrobacterial inhibitors
11/14/2007CN100348596C Indole-3-carboxamides as glucokinase(GK) activators
1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 628